Our study demonstrated that AUNIP had positive association with TMB and MSI in BLCA, SARC, and STAD, and patients with high AUNIP expression in these three types of tumors were more susceptible to immunotherapy. This evidence concerns the gene AUNIP and bladder transitional cell carcinoma.